Cardiovascular risk factor in MPN patients-Reference-Cited by-同舟云学术

Cardiovascular risk factor in MPN patients

Published:2020-01-30 Issue:3 Volume:50 Page:640-641
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Accurso Vincenzo^ORCID,Santoro Marco,Mancuso Salvatirce,Siragusa Sergio

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11239-020-02049-z.pdf

Reference8 articles.

1. Seguro FS, Teixeira LLC, da Rosa LI, da Silva WF (2020) Risk factors and incidence of thrombosis in a Brazilian cohort of patients with Philadelphia-negative myeloproliferative neoplasms. J Thromb Thrombolysis. https://doi.org/10.1007/s11239-019-02029-y

2. Arber DA, Orazi A, Hasserjian R et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127:2391–2405

3. Santoro M, Accurso V, Mancuso S, Carlisi M et al (2019) Comparison between thrombotic risk scores in essential thrombocithemia in essential thrombocythemia and survival implications. Hematol Oncol 37(4):434437

4. Accurso V, Santoro M, Mancuso S, et al (2020) Cardiovascular risk in essential thrombocythemia and polycythemia vera: thrombotic risk and survival. MJHID 12(1):e2020008

5. Finazzi G, Barbui T (2005) Risk-adapted therapy in essential thrombocythemia and polycythemia vera. Blood Rev 19:243–252

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Risk in Philadelphia-Negative Myeloproliferative Neoplasms: Mechanisms and Implications—A Narrative Review;Current Issues in Molecular Biology;2024-08-02

2. Overview of dyslipidemia and metabolic syndrome in myeloproliferative neoplasms;World Journal of Clinical Oncology;2024-06-24

3. Ph-Negative Chronic Myeloproliferative Neoplasms;Comprehensive Hematology and Stem Cell Research;2024

4. Renin-angiotensin inhibitors reduce thrombotic complications in Essential Thrombocythemia and Polycythemia Vera patients with arterial hypertension;Annals of Hematology;2023-08-21

5. Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review;Biomedicines;2023-01-28